EMAIL THIS PAGE TO A FRIEND

Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology

Old and new therapeutic developments in steroid treatment in Duchenne muscular dystrophy.


PMID 22655511

Abstract

Steroids have been used since two decades and several trials were conducted to establish their efficacy in DMD patients with various regimens. The clinical outcomes showed increased function in the treated boys, and in a single trial with deflazacort, prolongation of ambulation but with different side effects. Steroids clinical efficacy is now established. The main concern is to increase steroid efficacy and decrease side effect and toxicity. A trial comparing daily prednisone, deflazacort and intermittent glucocorticoids (prednisone 10 days on/10 days off) (FOR-DMD) is starting under NIH grant. The primary outcomes will be muscle strength, forced vital capacity and patient/parents satisfaction.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

SML0123
Deflazacort, ≥98% (HPLC)
C25H31NO6